Evidence-based oncology for patients & families

What do the
clinical trials
actually say?

Plain-language summaries of landmark cancer research, updated as they are published. Plus a tool to help you find clinical trials near you.

480+
landmark oncology trials in our curated library, updated regularly
Weekly
new plain-language summaries published every week
Free
no sign-up, no paywalls, no pharmaceutical sponsorship — ever

Built for patients, written by a doctor

Most health websites tell you what cancer is. This one tells you what the research says about treating it — trial by trial, in plain English.

01
Read the evidence

Every week a new summary of a landmark clinical trial — what was tested, what was found, and what it means for patients. No jargon, no spin.

02
Find a trial

Our AI-powered tool asks about your cancer type, treatment history, and location — then searches ClinicalTrials.gov and shows you trials you may actually qualify for.

03
Talk to your oncologist

Everything here is a starting point. Bring what you find to your next appointment — better informed, with better questions. Your doctor makes the final call.

What the trials say

Plain-language summaries of phase II and III clinical trials — now more than 30, spanning cancers of the breast, lung, prostate, kidney, liver, stomach, skin, colon, and more. Each explains what was studied, what the results showed, and what it means if you have that cancer.

Prostate · Theranostics
The VISION trial: targeted radiation for advanced prostate cancer
A radioactive drug that homes in on a protein flag on cancer cells — a landmark for "theranostics," where the same target is used to both find and treat the cancer.
Read the full summary →
Melanoma · Immunotherapy
CheckMate 067: immunotherapy that changed advanced melanoma
For a cancer once survivable only for months, two immunotherapy drugs together helped more than half of people be alive four years later — a durable benefit that redefined the disease.
Read the full summary →
Liver · Immunotherapy
IMbrave150: immunotherapy for advanced liver cancer
The first treatment in over a decade to help people with advanced liver cancer live longer than the old standard pill — while better preserving quality of life.
Read the full summary →
Rectal · Organ preservation
The OPRA trial: keeping your rectum in rectal cancer
Giving all chemotherapy and radiation first, then watching closely, let about half of patients keep their rectum and avoid major surgery — with the same cancer survival.
Read the full summary →
Breast · Immunotherapy
KEYNOTE-522: changing the standard of care for triple-negative breast cancer
How pembrolizumab added to chemotherapy before and after surgery cleared more tumors, lowered the risk of recurrence, and improved survival.
Read the full summary →
Colorectal · Exercise
The CHALLENGE trial: can exercise after colon cancer treatment improve survival?
A landmark phase III trial that asked a deceptively simple question — and got a surprising answer about structured exercise after curative treatment.
Read the full summary →

There may be a trial that fits your situation

Most patients never know about trials they might qualify for. Our tool asks the right questions — about your cancer type, treatment history, and where you live — and searches for recruiting trials near you.

Conversational AI intake
Live ClinicalTrials.gov data
Eligibility filtering
North America-wide
Start the trial finder →
"What I hear most often from patients is not fear — it's frustration at not knowing what the evidence actually says about their situation."

I've been a practicing medical oncologist for over 15 years. I created this site because the gap between what we know from clinical trials and what patients are able to access in plain language is enormous — and entirely unnecessary.

Everything published here is based on peer-reviewed trial evidence. I write under a pen name to protect my patients' privacy, but the expertise is real.

A practicing medical oncologist
Medical Oncologist · 15+ years clinical experience · No conflicts of interest

Only peer-reviewed evidence

Every summary is based on published phase II or III clinical trial data. No anecdote, no supplement claims, no unproven therapies — and where popular claims don't hold up to scrutiny, we say so clearly.

No pharmaceutical sponsorship

This site accepts advertising but has no relationship with any pharmaceutical company. No drug company has influenced, reviewed, or paid for any content published here.

Not medical advice

Everything here is a starting point for conversations with your own oncologist — not a substitute for them. Your doctor knows your full situation in ways no website ever can.